Stocks and InvestingStocks and Investing
Thu, February 3, 2022
Wed, February 2, 2022
Tue, February 1, 2022
Mon, January 31, 2022

Joseph Pantginis Maintained (CAPR) at Strong Buy with Increased Target to $18 on, Jan 31st, 2022


Published on 2024-10-27 19:30:17 - WOPRAI, Joseph Pantginis
  Print publication without navigation


Joseph Pantginis of HC Wainwright & Co., Maintained "Capricor Therapeutics, Inc." (CAPR) at Strong Buy with Increased Target from $14 to $18 on, Jan 31st, 2022.

Joseph, nor any peers, have made any analyst calls on CAPR in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30